Old Web
English
Sign In
Acemap
>
authorDetail
>
Markus Schmutz
Markus Schmutz
Medicine
Pharmacodynamics
Adverse effect
Risk assessment
Pharmaceutical industry
5
Papers
62
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Toxicity testing in the 21st century beyond environmental chemicals
2015
ALTEX-Alternatives to Animal Experimentation
Costanza Rovida
Shoji Asakura
Mardas Daneshian
Hana Hofman-Huether
Marcel Leist
Leo Meunier
David M. Reif
Anna Rossi
Markus Schmutz
Jean Pierre Valentin
Joanne Zurlo
Thomas Hartung
Show All
Source
Cite
Save
Citations (61)
Toxicity Testing in the 21 st Century Beyond Environmental Chemicals
2015
Costanza Rovida
Shoji Asakura
Mardas Daneshian
Hana Hofman-Huether
Marcel Leist
Leo Meunier
David M. Reif
Anna Rossi
Markus Schmutz
Jean Pierre Valentin
Joanne Zurlo
Thomas Hartung
Show All
Source
Cite
Save
Citations (1)
Utilisation de monohydroxycarbamazepine pour preparer un medicament destine au traitement de troubles affectifs et de l'attention et de douleurs neuropathiques
2002
Markus Schmutz
Show All
Source
Cite
Save
Citations (0)
Combination comprising an inhibitor of P-gp and an anticonvulsant.
2002
Wolfgang Löscher
Heidrun Potschka
Markus Schmutz
Show All
Source
Cite
Save
Citations (0)
Verwendung von Monohydroxycarbamazepin bei der Behandlung von neuropathischen Schmerzen und verwandten Erkrankungen
2002
Markus Schmutz
Show All
Source
Cite
Save
Citations (0)
1
map